• Elobixibat hydrate: Selective IBAT Inhibitor for Constipatio

  2026-06-25

  Elobixibat hydrate is a potent ileal bile acid transporter inhibitor used for chronic idiopathic constipation and metabolic modulation in type 2 diabetes mellitus. Its unique mechanism elevates colonic bile acids, activating TGR5 and promoting GLP-1 secretion, leading to improved motility and metabolic outcomes.

• miR-18a Drives Glioblastoma by Suppressing ALOXE3-Mediated F

  2026-06-24

  The reference study uncovers a novel oncogenic axis in glioblastoma, demonstrating that miR-18a directly targets and downregulates ALOXE3, thereby impairing ferroptosis and enhancing tumor cell migration. These findings provide mechanistic insight into lipid metabolism in GBM and highlight the miR-18a/ALOXE3 pathway as a promising target for therapeutic intervention.

• Macrophage Membrane-Camouflaged Nanoparticles for Glioblasto

  2026-06-23

  This study introduces macrophage membrane-camouflaged nanoparticles capable of crossing the blood-brain barrier for synergistic gene silencing and photodynamic therapy in glioblastoma. The approach demonstrates enhanced tumor targeting, effective STAT3 silencing, and improved antitumor efficacy in preclinical models.

• HotStart Universal 2X Green qPCR: Advancing Tumor Gene Expre

  2026-06-23

  Discover how HotStart Universal 2X Green qPCR Master Mix elevates precision in gene expression quantification and DNA amplification monitoring, with unique insights into its role in cancer stemness research. Explore protocol strategies, melt curve analysis, and practical lessons from recent LUAD metastasis studies.

• Advancing Alternative Splicing Modulation with TG003 Clk Inh

  2026-06-22

  This thought-leadership article explores the mechanistic basis and translational promise of TG003, a potent Cdc2-like kinase (Clk) inhibitor, for researchers investigating alternative splicing, platinum resistance, and exon-skipping therapies. Integrating recent evidence on CLK2’s role in ovarian cancer chemoresistance, we discuss strategic approaches for leveraging TG003 in preclinical workflows and highlight the unique value APExBIO brings to the field.

• Sulfo-NHS-Biotin in Phage Diagnostics & Complex Assays

  2026-06-22

  Explore how Sulfo-NHS-Biotin empowers advanced diagnostic assays, including phage-layer interferometry in challenging sample matrices. This article uncovers unique technical insights into sulfo nhs biotin's role beyond standard protein labeling, bridging biochemical innovation with next-generation antimicrobial research.

• IEM 1460: Precision AMPA Receptor Blocker for Neuroprotectio

  2026-06-21

  IEM 1460 empowers neuroscience researchers to dissect excitotoxicity and synaptic plasticity with unmatched selectivity, enabling high-reproducibility assays for neuroprotection and synaptic modulation. Explore robust workflows, troubleshooting strategies, and novel comparative insights that maximize the translational power of this selective AMPA receptor blocker.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-06-20

  Schwartz's dissertation introduces a refined in vitro framework for distinguishing between proliferative arrest and cell death, enhancing the precision of anti-cancer drug evaluation. This nuanced approach has practical implications for the study of novel PARP inhibitors, such as AZD2461, especially in breast cancer and drug-resistance research.

• CP-673451 in ATRX-Deficient Glioma: Selectivity, Protocols,

  2026-06-19

  Explore the role of CP-673451, a selective PDGFRα/β inhibitor, in advanced cancer research with a focus on ATRX-deficient glioma. This article delivers unique protocol guidance and practical insights drawn from recent peer-reviewed findings.

• Optimizing Cancer Metabolism Research with CB-839 (Telaglena

  2026-06-19

  This scenario-driven article explores how CB-839 (Telaglenastat, SKU B4799) addresses prevalent challenges in cancer metabolism research. By anchoring recommendations in peer-reviewed data and practical lab experience, we highlight its performance in glutaminolysis inhibition assays, assay reproducibility, and vendor reliability—enabling researchers to generate robust, actionable results.

• Niclosamide (SKU B2283): STAT3 Inhibitor Solutions for Cance

  2026-06-18

  This scenario-driven article addresses core laboratory challenges in cancer research by demonstrating how Niclosamide (SKU B2283) provides reproducible, literature-backed solutions for STAT3 pathway interrogation, apoptosis, and cell cycle studies. Designed for biomedical scientists, it integrates practical Q&A, protocol guidance, and vendor comparison to optimize outcomes in cell viability and cytotoxicity workflows.

• Hydrocortisone in EMT and Barrier Function: Advanced Researc

  2026-06-18

  Explore the multifaceted role of hydrocortisone, a glucocorticoid hormone, in cutting-edge inflammation model research and EMT modulation. This article uniquely bridges cellular barrier studies with EMT model innovation, offering actionable protocols and interpretation for translational scientists.

• Pazopanib (GW-786034): Applied Workflows in Angiogenesis Inh

  2026-06-17

  Pazopanib (GW-786034) empowers researchers to dissect angiogenesis and tumor growth suppression with high reproducibility—especially in genetically defined cancer models. Discover protocol-anchored guidance, troubleshooting tips, and translational insights drawn from the latest ATRX-deficient glioma research and beyond.

• Bradykinin: Endothelium-Dependent Vasodilator in Research

  2026-06-17

  Bradykinin is a potent endothelium-dependent vasodilator peptide used to model vascular permeability and blood pressure regulation. Its utility in pain and inflammation research is based on well-characterized mechanisms. APExBIO’s BA5201 Bradykinin is a gold-standard tool for experimental studies requiring precise modulation of vascular tone.

• CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal Stu

  2026-06-16

  CA-074 Me is a potent, cell-permeable cathepsin B inhibitor with nanomolar IC50 and high selectivity, enabling precise interrogation of lysosomal pathways and regulated cell death. This article details its mechanism, validated uses in necroptosis and apoptosis research, and critical considerations for workflow integration.

7804 records 9/521 page Previous Next First page 上5页 678910 下5页 Last page